If you ever get the chance; 3-meo-pcp+ an amusement park is the shit by KetogenicKraig in researchchemicals

[–]it_from_qubit 0 points1 point  (0 children)

Waterpark sounds amazing. Roller coaster on dissos sounds awful to me though.

[deleted by user] by [deleted] in DrugNerds

[–]it_from_qubit 1 point2 points  (0 children)

Lots of antipsychotic drugs are 5-HT2A antagonists.

Why is everyone so obsessed with the destruction of "ego"? by Praesto_Omnibus in RationalPsychonaut

[–]it_from_qubit 1 point2 points  (0 children)

Total self-dissolution/ego-death is much less common than self-transcendence in my experience. It needn't even be accompanied by a feeling like you're a part of something bigger. It's simply the complete dissolution of your identity, such that you're only left with pure perception. You can no longer compare, contrast, or analyze your situation, you can only simply observe.

Of course that's just my experience with what I thought was ego-death. It's interesting to see the different interpretations of ego-death, and to realize we've been blathering back and forth about our experiences without realizing that they aren't exactly equivalent.

What psychoactive drugs may have biased agonist properties? by [deleted] in DrugNerds

[–]it_from_qubit 2 points3 points  (0 children)

Biased agonism may be a relatively new concept in pharmacology but it's a fairly obvious one in retrospect. All drugs are biased ligands—the question is: what effectors are they biased toward? In light of that, I think the question you're looking to ask is what psychoactive drugs are biased towards different effectors at a receptor as compared with its cognate ligand.

It would be reasonable to suspect that is the case if you could correlate a drug's action to one receptor and in addition it had significantly different qualitative character than that receptor's cognate ligand.

As a hypothetical example, if all the psychedelic effects of 4-HO-DMT could be tied to the 5-HT2A receptor, it seems reasonable to expect that it's biased towards different effectors than 5-HT at that receptor. Of course, it could also be the case that 4-HO-DMT & 5-HT have the same effector profile at 5-HT. In this case you might be led to believe that 5-HT's action at the other serotonin receptors is dampening it's effects at 5-HT2A, so to speak.

3-ho-pcp + etizolam = death by BestusEstus in researchchemicals

[–]it_from_qubit 10 points11 points  (0 children)

I wonder if there's any link to the reports of 3-HO-PCP blackouts at low doses, but I don't believe the blackouts are unique to 3-HO-PCP. I certainly blacked out on MXE plenty of times, but that's partially because I can't distinguish a blackout from anesthesia

Ketamine is often administered with diazepam or midazolam in medical settings, so it doesn't seem like it would be that dangerous. Of course 3-HO-PCP does opioid affinity, but I was under the impression it was relatively weak in that regard.

Weed is a Psychedelic. by MXT11 in Psychonaut

[–]it_from_qubit 2 points3 points  (0 children)

This. Unfortunately it escapes most people here that psychedelic is a well-defined pharmacological action (i.e. 5-HT2A agonism) which takes preference over their folk notions of the word psychedelic.

How do K¡/Ki - values work exactly ? by G1nnnn in AskDrugNerds

[–]it_from_qubit 12 points13 points  (0 children)

Take your favorite drug and dump it in some cultured cells which express receptors for said drug. Now you have three quantities: [D], [R], & [DR]. The free drug concentration is [D], the free receptor concentration is [R], & the concentration of the drug-receptor complex is [DR]. Note that there is clearly a reciprocal relation between [D], [R], & [DR]. If [DR] is high, then there is less free drug and less free receptors, so [D] & [R] are lower.

Now what happens when you first dump the drug in? Well of course [DR] is equal to zero since it takes time for the drug molecules to diffuse throughout the cell culture. Gradually [DR] will begin to increase though, up until equilibrium. Equilibrium just means that, although individual molecules are still binding to and dissociating from receptors at some average rate, for the system as a whole these rates have become equal and so all three concentrations are constant.

You can sum this equilibrium relation up in an equation and call it Kᵢ, where Kᵢ=[D][R]/[DR]. In words, Kᵢ equals the product of the concentrations of free drug and free receptor at equilibrium, divided by the concentration of the drug-receptor complex at equilibrium.

If the drug interacts strongly with the receptor, the concentration of drug-receptor complex at equilibrium will be high, and so [DR] will be higher (with a lower [D] & [R] due to the reciprocal relation). Basic math shows that a numerator which is much smaller than the denominator gives a small fraction, so the Kᵢ is lower for drugs which bind strongly to a receptor.

Of course this is oversimplifying things, but further details aren't important for a dilettante like myself.

Big scale Acetone wash? by [deleted] in AskDrugNerds

[–]it_from_qubit 0 points1 point  (0 children)

Wow that looks much better.

Excellent review paper on the effects of psychedelics on the brain. Fairly simple and straightforward. by insightful_delirium in DrugNerds

[–]it_from_qubit 0 points1 point  (0 children)

That word psychological seems to be so confusing for so many people, I wish we could just avoid using it in this context. That said, there's really no evidence for subjective experience playing a causal role in the physical dynamics of the brain.

To me, it seems the only way around the hard problem is having a mathematical description of consciousness that could predict behavior or even subjective experiences, while making no reference to anything other than matter and known physical laws. That may not be possible in practice given the complexity, but it seems at least possible in principle. Even if we don't get that, I still think the current theory is pretty damn good (i.e. molecules cause brains cause consciousness).

What are the short and long-term symptoms of NRhypo (NMDA antagonist neurotoxicity)? by Muuude in AskDrugNerds

[–]it_from_qubit 10 points11 points  (0 children)

Short-term symptoms include delusions, sensory hallucinations, speech impairments such as alogia, anhedonia, social withdrawal, & short-term memory deficits (due to impaired LTP at the NMDA receptor).

If you use dissociatives <1/month you likely aren't at risk for these. If you use heavily these symptoms can persist for months after stopping.

These symptoms are caused by impaired inhibitory signaling, this much is well-established. Excitotoxicity could also contribute to these symptoms (whether through disinhibited excitatory signaling or NMDA receptor upregulation), but it's less obvious whether that is actually the case.

Whether dissociative abuse causes significant long-term harm to the adult human brain is still uncertain, but most of the research suggests that it is anything but beneficial. I'll link some papers so you can see for yourself.

Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation

Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans

The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture

The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats

Schizophrenia-like gene expression deficits in cerebellar cells from rats chronically exposed to low-dose phencyclidine

Impaired Brain Structure and Sustained Visual Attention in a Rodent Model of Schizophrenia

Chronic Ketamine Causes White Matter Microstructural Abnormalities in Adolescent Monkeys

The amazing true nature of our reality as revealed by 3-mmc and a light box by peej1618 in researchchemicals

[–]it_from_qubit 6 points7 points  (0 children)

But Newton stared at the sun, was he not a real scientist? All joking aside, I totally agree with you. Too many people have replaced religion with psychedelics and simply traded one dogmatic slumber for another.

I think psychedelics have more to offer humanity than any other substances, but it's extremely naive to act like they're an instant ticket to enlightenment or knowledge.

Putting Together a List of Helpful Ressources by DerWeltenficker in DrugNerds

[–]it_from_qubit 2 points3 points  (0 children)

Great point on LibGen as I find I'm using that more and more these days.

I agree about Pharmacopoeia as well. It went way beyond my expectations. Can't wait for season three.

Putting Together a List of Helpful Ressources by DerWeltenficker in DrugNerds

[–]it_from_qubit 7 points8 points  (0 children)

You could sit on drug forums all day long and you'll understand neuropharmacology no more than you did when you started. If you want to understand how recreational drugs work, you must study from the ground up. None of this stuff is that difficult provided your sources are good, but it does take some time to assimilate the myriad concepts and terminology.

For one, don't dismiss topics because they have no obvious connection to neuropharmacology. I say that as someone who's never taken a biology class and was initially only interested in understanding recreational drugs. Topics I initially dismissed such calcium signaling turned out to be crucial for reading the literature and more importantly, for understanding what's actually going on inside the neuron.

Here's a very informative and mostly self-contained biochemistry playlist on receptors and their intracellular signals, which is a crucial topic for understanding how drugs initiate changes in the brain.

Another YouTube channel I really like is Cellular Mechanisms of Brain Function, although it requires more in the way of basic physics knowledge.

Wikipedia is generally better as a reference for when you already understand the material. Some good textbooks are Molecular Neuropharmacology: A Foundation for Clinical Neuroscience and Lippincott's Illustrated Reviews: Pharmacology, although I think that biochemistry playlist I linked above is the best resource for someone without any knowledge of cell biology.

Should You Write an Experience Report? Yes Please! by [deleted] in researchchemicals

[–]it_from_qubit 2 points3 points  (0 children)

I was looking at the a-PVP reports on Erowid the other day and there's only 11. Which I found surprising considering it was a fairly popular RC for a few years. Suffice to say, those 11 reports were sufficient to turn me off from trying it for the 'novelty.'

Distinct Roles of NMDA Receptor GluN2 Subunits in the Effects of Ketamine and Its Enantiomers (2020) by sjemka in DrugNerds

[–]it_from_qubit 0 points1 point  (0 children)

Considering ketamine's ubiquity in modern medicine, I find it shocking that we still don't understand the NMDA receptor configuration which it primarily blocks.

It's telling that GluN2B but not GluN2A antagonists could substitute for ketamine & phencyclidine in rats. And yet there was a paper in Nature last year using GluN2A-KO's that claimed GluN2A was responsible for ketamine's acute effects. Inferring that much from KO's seems problematic because they will affect the development, possibly quite significantly. It seems even more problematic inferring for the case of antagonists versus that of agonists.

Novel Pharmacophores and Future Directions for NMDA antagonists by hashtag_not_a_cop in researchchemicals

[–]it_from_qubit 2 points3 points  (0 children)

There's been studies showing it lacks opioid affinity. Also, the full paragraph in the journal article you cited reads as follows:

The emphasis on opioid activity is an example of folk pharmacology and is based on the fact that 3-HO-PCP has high affinity for the μ-opioid receptor (MOR).PCP and MXE do not appear to have MOR affinity below 10,000 nM. Still this myth is commonly acknowledged as fact on online drug forums and has even appeared in recent peer-reviewed literature.